Health Discovery Corporation (MelApp)
Health Discovery Corporation, maker of the MelApp mobile application, entered into an FTC consent order in April 2015 under Matter No. 132-3211. The FTC alleged deceptive and misleading conduct related to health claims made for MelApp, which purportedly used image analysis to assess melanoma risk. The consent order resolved allegations of unsubstantiated health claims in the app's advertising and marketing. The matter was resolved through a Part 2 Consent, imposing ongoing compliance obligations on the company.
Required actions (1)
Part 2 Consents
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most medical spa / aesthetics sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker